Bank of Montreal’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Bank of Montreal’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-282,476	Closed	-$2.86M	–	4465
2022 Q4	$2.86M	Sell	282,476 -29,938	-10%	-$300K	﹤0.01%	1621
2022 Q3	$3.1K	Buy	312,414 +62,514	+25%	+$618K	﹤0.01%	1601
2022 Q2	$2.49K	Sell	249,900 -100	-0%	-$981	﹤0.01%	1786
2022 Q1	$2.46M	Hold	250,000	–	–	﹤0.01%	1823
2021 Q4	$2.47M	Buy	250,000 +50,000	+25%	+$491K	﹤0.01%	1498
2021 Q3	$1.95M	Hold	200,000	–	–	﹤0.01%	2090
2021 Q2	$1.94M	Buy	+200,000	New	+$1.94M	﹤0.01%	2082

Bank of Montreal's BIOT Position: Q1 2023 in Review

Bank of Montreal sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 282,476 shares — an estimated $2.86M sold.

Bank of Montreal first reported a position in BIOT in Q2 2021 and held it in 7 quarters. The position peaked at $2.86M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Bank of Montreal reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Bank of Montreal sold 282,476 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $2.86M.
Bank of Montreal first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
Bank of Montreal's Biotech Acquisition Company Class A Ordinary Shares position peaked at $2.86M in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.